UK approves first gene-edited crop trial in Europe––for omega-3 oil boosting camelina

Screen Shot at AM
Professor Jonathan Napier is masterminding the new gene-edited plant project (Image credit: Paul Grover/Telegraph)

Gene-edited super-crops are to be sown in Britain in a European-first after scientists exploited a legal loophole.

The Government has quietly approved the farming of gene-edited (GE) Camelina oilseed crops as part of a trial to super-charge the plants to produce Omega 3 fish oils, one of the most popular food supplements.

The pilot was approved because, unlike genetically modified (GM) plants, the Camelina oilseed crops contain no foreign DNA. Instead, they had their genetic code altered in a way that could have happened naturally.

Scientists say gene-editing can cut the time it takes to engineer new plants from decades to months. They argue embracing the new technology is vital if Britain is to benefit from GE crops and help maintain a sustainable source of fish oils in face of depleted ocean stocks

The trial starts as the European Court of Justice prepares to decide whether GE plants can be legally treated as if they were conventional crops across the EU.

Critics, however, accused Defra (Department of Environment, Food and Rural Affairs) of pre-empting a decision by the court which could end up requiring GM-style regulation of GE crops.

Read full, original post: Exclusive: Gene-edited super-crops to be grown in UK for the first time

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
ChatGPT-Image-May-12-2026-11_27_01-AM-2
AI likely to improve health care, research shows—but not for blacks and ethnic minorities
ChatGPT-Image-May-7-2026-01_23_27-PM-2
Viewpoint: Will AI democratize personalized cancer treatment or fuel medical misinformation?
vax-misinformation-main
Facts & Fallacies Podcast: Limit free speech to blunt social media misinfo?

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.